Manitok Energy Inc. Announces Closing of the Final Tranche of Its Private Placement and Raising a Combined Gross Proceeds of $10.6 Million Feb 17, 2016
RedHill Biopharma Announces Successful PK Study With BEKINDA™ 12 mg and Submission to FDA of IBS-D Phase II Study Protocol Feb 12, 2016
RedHill Biopharma Receives Notice of Allowance of Fifth U.S. Patent Covering RHB-104 Phase III Crohn’s Disease Program Feb 11, 2016
RedHill Biopharma Announces Collaboration with Germany’s Fraunhofer Institute for Oncology Drug RP101 Feb 9, 2016
Stornoway Announces Advanced Renard Construction Schedule With Reduced Cost To Complete Forecast Feb 4, 2016
Manitok Energy Inc. Announces Closing of the Second Tranche of Its Private Placement and Raising a Combined Gross Process of $10.5 Million Jan 27, 2016
Resverlogix’s Manuscript on BET-inhibitor apabetalone (RVX-208) Accepted into the Atherosclerosis Journal Jan 26, 2016
Fission Targets R600W, Triple R and High-Priority Regional Drilling With 35 Hole Program Jan 22, 2016
Manitok Energy Inc. Provides Update on Its Brokered Private Placement of Up to $20 Million Jan 22, 2016